Heart surgery risk for chronically ill patients may be explained by cell aging
NCT ID NCT07389785
First seen Feb 05, 2026 · Last updated Jun 22, 2026 · Updated 18 times
Summary
This research program studies why people with multiple long-term conditions like kidney or lung disease are more likely to suffer organ damage after heart surgery. Researchers will analyze existing data from over 3,000 patients to understand how aging-related changes in heart cells increase vulnerability. The goal is to identify potential drug targets that could protect organs during surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Leicester
Leicester, Leicester, LE1 7RH, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could identify new drug targets to protect organs during heart surgery, especially for people with multiple long-term conditions.
What could go wrong
This is an observational study using existing data, not a clinical trial testing a treatment. It may not lead to any new therapies, and findings may not apply to all patients.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.